Steven Capuano has an observation about how small business owners treat their first patent filing, and it tends to make lawyers uncomfortable. The filing itself, he says, is the easy part. What happens in the 12 months afterward is where most founders quietly surrender the leverage they just paid for.
Capuano launched his product company earlier this year with four patented products in the wellness and rehabilitation tools category. He filed all four before he went to market, before he showed a prototype to a potential distributor, and before he had a conversation with a manufacturer that involved sending a CAD file. That order of operations was deliberate, and in his telling it had less to do with the eventual court-ready intellectual property position and more to do with the commercial conversations he knew were coming next.
“A patent is a legal instrument, but patent pending is a sales tool,” Capuano says. “It changes how people on the other side of the table talk to you. The number of founders who pay for the filing and then never use it that way is what surprises me.”
The Distributor Conversation Changes When You File First
The first place a provisional patent application starts earning its keep is in distribution negotiations. Distributors in any product category are pattern-matching on risk, and one of the first risks they evaluate is whether the product they are considering carrying can be knocked off within six months by a cheaper competitor overseas. A distributor who invests in category positioning, trade show presence, and sales rep training for a product that gets commoditized a quarter later has wasted the investment.
Patent pending status, used honestly, removes that risk from the conversation. It signals that the founder has made the filing, that the design is on record with the USPTO, and that a direct copy carries legal exposure for whoever manufactures it. Distributors can evaluate the product on its merits rather than discounting their interest based on a worst-case scenario that no longer applies.
Capuano’s approach to those conversations is specific. He does not volunteer the patent status as a selling point, and he does not lead with it. He waits for the distributor to raise the question of competitive risk, which in his experience they almost always do, and then he answers it factually. The patent application is on file. The claims cover the design elements that matter for the category. The full non-provisional will be filed within the 12-month window.
The conversation shifts after that. The distributor stops evaluating whether the product is defensible and starts evaluating whether the commercial terms are workable. That is the conversation a founder wants to be having.
“A patent is a legal instrument, but patent pending is a sales tool. It changes how people on the other side of the table talk to you.”
Retail Buyers Ask a Different Question, and the Answer Is the Same
Retail buyers approach the same concern from a different angle. They are not worried about a cheap knockoff appearing on a competing distributor’s catalog. They are worried about a cheap knockoff appearing on their own shelves under a private label, sourced by their own buying team, six months after they gave the original product shelf space and helped it establish category demand.
That scenario is common enough in consumer product categories that experienced buyers build it into their evaluation. They ask what stops them from taking a successful product and commissioning a direct equivalent through their private label program once the category is proven. The answer, if the founder has not filed, is essentially nothing. The answer, if the founder has filed, is a legal obstacle that most retail legal departments will not sign off on.
The effect on the buyer conversation is not that the retailer becomes enthusiastic about the filing. The effect is that the filing takes the private label shortcut off the table and forces the retail relationship to be a real one, where the buyer either commits to carrying the original product on reasonable terms or walks away. For a small business, that binary outcome is vastly preferable to the alternative, which is a short-term placement that ends in being distributed by the retailer’s own version of the product.
Capuano is directly about the dynamic. “Retail is a hard channel for small brands in any category, but it gets a lot harder if you are selling a product that the retailer can reproduce internally without consequence. The filing is what makes the relationship a negotiation instead of a countdown.”
Manufacturers Respond to Patent Pending Because They Have to
The manufacturer relationship is where patent-pending status earns its keep in a way most founders underestimate. The conventional fear that an overseas contract manufacturer will receive the CAD files, produce the first run honestly, and then begin producing the same product for a competitor under a different label, is not a paranoid fantasy. It happens in every physical product category, and it happens to small businesses more than to large ones because the legal infrastructure is thinner.
A filed patent, even a provisional one, changes the calculus for a manufacturer in two ways. First, reputable contract manufacturers, particularly in the United States, track patent status on the products they produce and have internal policies against manufacturing designs that are patent protected for parties other than the patent holder. A filing gives the manufacturer a clean reason to decline a later request from another party. That protection is passive but real.
Second, and more importantly, the filing establishes a documentary record of the design as of a specific date. If a dispute arises later about whether a similar product was independently developed or copied, the priority date on the filing is the reference point. Manufacturers, distributors, and litigation counsel all treat that date as foundational. Without it, the founder’s position in any future dispute is substantially weaker, even if the product was genuinely original.
Capuano recommends that founders make the filing date part of the manufacturing conversation explicitly. Not as a threat or as a preamble to the commercial terms, but as a factual element of the commitment. The manufacturer should know the product is filed, the filing date should be in the supplier file, and the expectation of design confidentiality should be set in writing. That sequence turns a handshake into a paper trail.
The 12-Month Window Is Commercial Runway, Not Legal Runway
The standard framing of the 12 months that follow a provisional filing treats them as a window for refining the invention and preparing the non-provisional application. That framing is technically correct and commercially incomplete. The same 12 months are also the window during which a small business has its maximum leverage in commercial conversations, because the filing is active, the priority date is secured, and the founder has not yet committed to the more expensive full patent prosecution.
Capuano treats the window as a commercial sprint rather than a legal preparation period. During that 12 months, his priority is closing the distribution and retail conversations that benefit from patent-pending status, establishing the manufacturing relationship on terms that account for the filing, and generating enough revenue and market signal to make the non-provisional filing a clearly justified investment rather than a speculative one.
The founders who treat the 12 months as purely a legal countdown tend to miss the commercial opportunity embedded in the status. They emerge from the window with a granted patent and a business that has not used the interim period to establish the positions the patent was meant to defend. That outcome is worse than filing later would have been, because the patent protection is now in place to defend a position the business never built.
The Founders Who Do Not File Have a Different Problem
The mirror image of underusing patent-pending status is not filing at all. Capuano encounters this pattern frequently in the wellness and product categories he pays attention to, and he describes the consequence plainly.
A founder who brings a product to market without a filing is competing in a commoditized market by default. The distributor conversation becomes a margin negotiation because there is no reason to pay a premium for a product that can be replicated. The retail conversation becomes a shelf test that ends when the retailer’s buying team commissions the private label version. The manufacturer relationship becomes a hope that the contract manufacturer does not find a second customer for the same tooling. None of those outcomes is hypothetical, and none of them is avoidable once the product is in the market without protection.
The cost of preventing that outcome, he points out, is measured in thousands of dollars, not tens of thousands. A provisional patent application for a small entity typically runs between $3,000 and $6,000, including attorney fees, in 2026. Qualifying small entities receive a 60 percent discount on USPTO fees, and qualifying micro entities receive an 80 percent discount. The math is not the obstacle.
The obstacle, in his experience, is that founders who have not been through the process once tend to overestimate the complexity and underestimate the commercial return. They treat the filing as a legal expense rather than a commercial investment, and they defer it until the business is established enough to justify the cost. By the time the business is established enough, the moment to file has usually passed, because the product has been disclosed and the priority date window has closed.
What Patent Pending Does Not Do
Capuano is careful to distinguish what the filing accomplishes from what it does not. Patent pending status does not create demand for a product that the market does not want. It does not make a poorly designed product competitive. It does not substitute for distribution, marketing, or customer acquisition work. A founder who files and then expects the status alone to generate commercial momentum will be disappointed.
What the filing does is make the commercial work that follows more productive. Every conversation with a distributor, retailer, or manufacturer starts from a stronger position. Every negotiation has a clearer floor. Every competitive threat has a documented response. Those advantages compound across the first year of a product business in ways that are difficult to reproduce without the filing in place.
“The founders who use patent-pending well are not the ones who talk about it the most,” Capuano says. “They are the ones who build the commercial relationships the filing makes possible and let the filing do its work quietly in the background. If you do it right, the status is the least interesting thing about the conversation by the time it ends.”
The Filing Is a Decision, and the Decision Is Commercial
For founders in product categories where design is the differentiator, the decision to file a provisional patent is not primarily a legal decision. It is a commercial decision about how the business wants to negotiate with the partners it needs to reach its market. The filing costs are real but bounded. The commercial returns are less bound and accrue over the full 12-month window and beyond.
Capuano built his product company on four filings made before the first product shipped. The filings are not what made the business, but they are what made the commercial conversations that built the business possible in their current form. That distinction, between what the filing is and what the filing enables, is the one he wishes more small business founders understood before they decided whether to do it.
Steven Capuano is a product company founder whose portfolio includes four patented wellness and rehabilitation innovations launched in 2026. More at stevencapuano.com.
